|
|
Substance Name: Hydralazine hydrochloride [USP:JAN]
RN: 304-20-1
UNII: FD171B778Y
InChIKey: ZUXNZUWOTSUBMN-UHFFFAOYSA-N
Note
- A direct-acting vasodilator that is used as an antihypertensive agent.
Molecular Formula
- C8-H8-N4.Cl-H
Molecular Weight
- 196.6369
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Formulas
- Structure Descriptors
- Toxicity
Classification Codes
- Antihypertensive
- Antihypertensive Agents
- Drug / Therapeutic Agent
- Mutation Data
- Reproductive Effect
- Tumor Data
- Vasodilator Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Regulatory Agencies (Superlist Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Hydralazine hydrochloride [USP:JAN]
Synonyms
- 1(2H)-Phthalazinone, hydrazone, hydrochloride
- 1(2H)-Phthalazinone, hydrazone, monohydrochloride
- 1-Hydrazinophthalazine hydrochloride
- 1-Hydrazinophthalazine monohydrochloride
- Aiselazine
- Apresine
- Apresoline
- Apresoline hydrochloride
- Apresoline-esidrix
- CCRIS 334
- Dralzine
- EINECS 206-151-0
- HSDB 434
- Hydralazine chloride
- Hydralazine HCl
- Hydralazine hydrochloride
- Hydralazine monohydrochloride
- Hyperazin
- Hyperex
- Lopress
- Nor-press 25
- NSC 89394
- Phthalazinone, hydrazone, monohydrochloride
- Praparat 5968
- Rolazine
- Slow-Apresolin
- UNII-FD171B778Y
Systematic Names
- 1(2H)-Phthalazinone, hydrazone, monohydrochloride
- Hydralazine hydrochloride
- Phthalazine, 1-hydrazino-, monohydrochloride
- Phthalazine, 1-hydrazinyl-, hydrochloride (1:1)
Superlist Name
- Hydralazine hydrochloride
Mixture Names
- Apresazide
- Bidil
- H.H. 25/25
- H.H. 50/50
- PRA 027
- Ser-Ap-Es
- Unipres
Registry Numbers
CAS Registry Number
- 304-20-1
FDA UNII
- FD171B778Y
Other Registry Numbers
- 1202866-95-2
- 40671-54-3
Related Registry Number
- 86-54-4 (Parent)
System Generated Number
- 0000304201
Molecular Formulas
Molecular Formula
- C8-H8-N4.Cl-H
Molecular Formula Fragments
- C8-H8-N4
- Cl-H
- COMPONENT
Structure Descriptors
InChI
1S/C8H8N4.ClH/c9-11-8-7-4-2-1-3-6(7)5-10-12-8;/h1-5H,9H2,(H,11,12);1HInChIKey
ZUXNZUWOTSUBMN-UHFFFAOYSA-NSmiles
Cl.NNc1nncc2ccccc12Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 83mg/kg (83mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 101, Pg. 368, 1951. | |
mouse | LD50 | intravenous | 71mg/kg (71mg/kg) | Drugs in Japan Vol. -, Pg. 1006, 1995. | |
mouse | LD50 | oral | 188mg/kg (188mg/kg) | Oyo Yakuri. Pharmacometrics. Vol. 3, Pg. 97, 1969. | |
mouse | LD50 | subcutaneous | 73mg/kg (73mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION | Sapporo Igaku Zasshi. Sapporo Medical Journal. Vol. 6, Pg. 362, 1954. |
rat | LD50 | intravenous | 34mg/kg (34mg/kg) | Drugs in Japan Vol. 6, Pg. 619, 1982. | |
rat | LD50 | oral | 280mg/kg (280mg/kg) | Drugs in Japan Vol. -, Pg. 1006, 1995. |